{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:17:13Z","timestamp":1778066233459,"version":"3.51.4"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1093\/ijnp\/pyu036","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T17:16:04Z","timestamp":1432660564000},"source":"Crossref","is-referenced-by-count":25,"title":["Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 Using Pupillometry as a Translational Biomarker in Rat and Human"],"prefix":"10.1093","volume":"18","author":[{"given":"Linda M.","family":"Rorick-Kehn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer W.","family":"Witcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celedon R.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne B.","family":"Need","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie H.","family":"McKinzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Statnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey G.","family":"Suico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"McKinzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitra","family":"Tauscher-Wisniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles H.","family":"Mitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall R.","family":"Stoltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad J.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,1,29]]},"reference":[{"key":"key\n\t\t\t\t20170523194040_CIT0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"(2006)","journal-title":"Nat Rev Neurosci"},{"key":"key\n\t\t\t\t20170523194040_CIT0002","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-010-1832-9","article-title":"Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats","volume":"210","author":"Carr","year":"(2010)","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20170523194040_CIT0003","article-title":"Kappa selective opioid receptor antagonist","volume-title":"US Patent # US20090186873","author":"Diaz-Buezo","year":"(2009)"},{"key":"key\n\t\t\t\t20170523194040_CIT0004","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1476-5381.2008.00035.x","article-title":"Neutral antagonist activity of naltrexone and 6beta-naltrexol in naive and opioid-dependent C6 cells expressing a mu-opioid receptor","volume":"156","author":"Divin","year":"(2009)","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170523194040_CIT0005","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0022-3565(25)13068-1","article-title":"Comparative clinical pharmacology of short-acting mu opioids in drug abusers","volume":"277","author":"Greenwald","year":"(1996)","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170523194040_CIT0006","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrd4028","article-title":"Opioid receptor blocker shows promise in Phase II depression trial","volume":"12","author":"Harrison","year":"(2013)","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170523194040_CIT0007","doi-asserted-by":"crossref","first-page":"155ps119","DOI":"10.1126\/scitranslmed.3004873","article-title":"Next-generation treatments for mental disorders","volume":"4","author":"Insel","year":"(2012)","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20170523194040_CIT0008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(00)80005-8","article-title":"Nalmefene: blockade of intravenous morphine challenge effects in opioid abusing humans","volume":"60","author":"Jones","year":"(2000)","journal-title":"Drug Alcohol Depend"},{"key":"key\n\t\t\t\t20170523194040_CIT0009","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3565(25)31529-6","article-title":"Morphine-induced mydriasis and fluctuation in the rat: time and dose relationships","volume":"208","author":"Klemfuss","year":"(1979)","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170523194040_CIT0010","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1213\/01.ANE.0000116924.16535.BA","article-title":"The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers","volume":"99","author":"Knaggs","year":"(2004)","journal-title":"Anesth Analg"},{"key":"key\n\t\t\t\t20170523194040_CIT0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","article-title":"Dynorphin, stress, and depression","volume":"1314C","author":"Knoll","year":"(2010)","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20170523194040_CIT0012","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.jpainsymman.2005.01.012","article-title":"Pharmacokinetic-pharmacodynamic modeling of opioids","volume":"29","author":"Lotsch","year":"(2005)","journal-title":"J Pain Symptom Manage"},{"key":"key\n\t\t\t\t20170523194040_CIT0013","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jcph.286","article-title":"Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects","volume":"54","author":"Lowe","year":"(2014)","journal-title":"J Clin Pharmacol"},{"key":"key\n\t\t\t\t20170523194040_CIT0014","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study","volume":"350","author":"Mansour","year":"(1994)","journal-title":"J Comp Neurol"},{"key":"key\n\t\t\t\t20170523194040_CIT0015","doi-asserted-by":"crossref","first-page":"9981","DOI":"10.1523\/JNEUROSCI.23-31-09981.2003","article-title":"Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons","volume":"23","author":"Margolis","year":"(2003)","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170523194040_CIT0016","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2710.2010.01203.x","article-title":"Pupillometry in healthy volunteers as a biomarker of tramadol efficacy","volume":"36","author":"Matouskova","year":"(2011)","journal-title":"J Clin Pharm Ther"},{"key":"key\n\t\t\t\t20170523194040_CIT0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(02)02872-8","article-title":"Naloxone displacement at opioid receptor sites measured in vivo in the human brain","volume":"459","author":"Melichar","year":"(2003)","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20170523194040_CIT0018","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0306-4530(78)90013-6","article-title":"Effects of naltrexone on mood and neuroendocrine function in normal adult males","volume":"3","author":"Mendelson","year":"(1978)","journal-title":"Psychoneuroendocrinology"},{"key":"key\n\t\t\t\t20170523194040_CIT0019","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1021\/jm200789r","article-title":"Discovery of aminobenzyloxyarylamides as kappa opioid receptor selective antagonists: application to preclinical development of a kappa opioid receptor antagonist receptor occupancy tracer","volume":"54","author":"Mitch","year":"(2011)","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170523194040_CIT0020","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.lfs.2007.09.005","article-title":"In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC\/MS\/MS and the administration of three tracers simultaneously","volume":"81","author":"Need","year":"(2007)","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20170523194040_CIT0021","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"(1986)","journal-title":"Science"},{"key":"key\n\t\t\t\t20170523194040_CIT0022","first-page":"225","article-title":"Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine","volume":"105","author":"Rasmussen","year":"(2007)","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key\n\t\t\t\t20170523194040_CIT0023","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders","volume":"77","author":"Rorick-Kehn","year":"(2014)","journal-title":"Neuropharmacology"},{"key":"key\n\t\t\t\t20170523194040_CIT0024","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-4835(02)92024-5","article-title":"Dynorphin modulates ocular hydrodynamics and releases atrial natriuretic peptide via activation of kappa-Opioid receptors","volume":"75","author":"Russell","year":"(2002)","journal-title":"Exp Eye Res"},{"key":"key\n\t\t\t\t20170523194040_CIT0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1006\/exer.2000.0832","article-title":"Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist","volume":"70","author":"Russell","year":"(2000)","journal-title":"Exp Eye Res"},{"key":"key\n\t\t\t\t20170523194040_CIT0026","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.89.6.2046","article-title":"Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway","volume":"89","author":"Spanagel","year":"(1992)","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170523194040_CIT0027","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0022-3565(24)37115-0","article-title":"Delta opioid modulation of the binding of guanosine-5\u2019-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects","volume":"283","author":"Szekeres","year":"(1997)","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170523194040_CIT0028","author":"Tauscher","year":"(2012)"},{"key":"key\n\t\t\t\t20170523194040_CIT0029","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2967\/jnumed.112.112672","article-title":"Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for kappa-opioid receptors: a study in nonhuman primates","volume":"54","author":"Tomasi","year":"(2013)","journal-title":"J Nucl Med"},{"key":"key\n\t\t\t\t20170523194040_CIT0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3940(88)90345-X","article-title":"Systemic administration of naloxone produces analgesia in BALB\/c mice in the formalin pain test","volume":"84","author":"Vaccarino","year":"(1988)","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170523194040_CIT0031","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s002130000466","article-title":"Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats","volume":"150","author":"Wadenberg","year":"(2000)","journal-title":"Psychopharmacology (Berl)"},{"key":"key\n\t\t\t\t20170523194040_CIT0032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0376-8716(93)90070-7","article-title":"Opioid miosis: effects of lighting intensity and monocular and binocular exposure","volume":"31","author":"Weinhold","year":"(1993)","journal-title":"Drug Alcohol Depend"},{"key":"key\n\t\t\t\t20170523194040_CIT0033","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0006-8993(88)90594-X","article-title":"Effects of naltrexone on nucleus accumbens, lateral hypothalamic and ventral tegmental self-stimulation rate-frequency functions","volume":"462","author":"West","year":"(1988)","journal-title":"Brain Res"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/18\/2\/pyu036\/17487376\/pyu036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T03:20:34Z","timestamp":1748402434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article-lookup\/doi\/10.1093\/ijnp\/pyu036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,29]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,1,29]]},"published-print":{"date-parts":[[2015,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ijnp\/pyu036","relation":{},"ISSN":["1469-5111","1461-1457"],"issn-type":[{"value":"1469-5111","type":"electronic"},{"value":"1461-1457","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,29]]}}}